- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 64.48M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $67.89M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $86.95M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $56.23M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $62.96M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $219.97M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $227.05M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $131.72M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $151.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $213.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $232.57M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 58.8M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $256K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.62M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $18.44M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$20.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $45.12M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$13.11M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$8.92M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $40.5M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $18.83M |
| Revenue | Q1 2025 · Mar 31, 2024 | $59.33M |